Boston Therapeutics, Inc. (25) | Business Finance (18)

Browse by Subcategory

Recent Contracts

Consent, Amendment and Waiver, dated March 22, 2022 (Filed With SEC on March 24, 2022)
Securities Purchase Agreement, dated March 23, 2022 (Filed With SEC on March 24, 2022)
Form of Warrant, dated March 23, 2022 (Filed With SEC on March 24, 2022)
Form of Senior Secured Convertible Note, dated February 28, 2022 (Filed With SEC on March 1, 2022)
Form of Exchange Agreement, dated June 25, 2021, with existing holders of convertible promissory notes (Filed With SEC on June 29, 2021)
Guaranty, dated June 25, 2021, by each of the Companys subsidiaries in favor of HT Investments MA LLC, in its capacity as collateral agent (Filed With SEC on June 29, 2021)
Security and Pledge Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc, each of the Companys subsidiaries and HT Investments MA LLC, in its capacity as... (Filed With SEC on June 29, 2021)
Registration Rights Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc. and the buyers signatory thereto (Filed With SEC on June 29, 2021)
Certificate of Designation Series B Preferred Stock (Filed With SEC on February 2, 2021)
Consent, Amendment and Waiver, dated February 24, 2022 (Filed With SEC on March 1, 2022)
Securities Purchase Agreement, dated February 28, 2022 (Filed With SEC on March 1, 2022)
Form of Warrant, dated February 28, 2022 (Filed With SEC on March 1, 2022)
Securities Purchase Agreement, dated June 25, 2021, by and between Boston Therapeutics, Inc. and the buyers signatory thereto (Filed With SEC on June 29, 2021)
Form of Warrant, dated June 25, 2021 (Filed With SEC on June 29, 2021)
Form of Senior Secured Convertible Note, dated June 25, 2021 (Filed With SEC on June 29, 2021)
Form of 10% Promissory Note issued by Nanomix, Inc. to Boston Therapeutics Inc (Filed With SEC on May 12, 2021)
Form of Promissory Note dated April 30, 2021 (Filed With SEC on May 12, 2021)
Form of Exchange Agreement (Filed With SEC on February 2, 2021)